Humana (FRA:HUM) ROE % Adjusted to Book Value: 23.74% (As of Mar. 2026)


FRA:HUM Humana Inc FRA:HUM
87 GF Score
Price €344.00
GF Value €318.92
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Humana ROE % Adjusted to Book Value?

Humana FRA:HUM +0.58% 87 ROE % Adjusted to Book Value is 23.74% as of Mar. 2026. GuruFocus rates FRA:HUM with a GF Score™ of 87/100 and a GF Value™ of €318.92 (Fairly Valued). The stock has 7 warning signs investors should review.

Humana's ROE % for the quarter that ended in Mar. 2026 was 26.35%. Humana's PB Ratio for the quarter that ended in Mar. 2026 was 1.11. Humana's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 23.74%.


Humana ROE % Adjusted to Book Value Related Terms


Humana ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Humana's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humana ROE % Adjusted to Book Value Chart

Humana Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.44 4.46 4.57 4.02 3.80

Humana Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.04 7.38 2.55 -10.13 23.74

FRA:HUM vs CNC, CI, MOH: ROE % Adjusted to Book Value Comparison

For the Healthcare Plans subindustry, Humana's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humana ROE % Adjusted to Book Value vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Humana's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Humana's ROE % Adjusted to Book Value falls into.


FRA:HUM
87GF Score
Humana Inc FRA:HUM
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Humana ROE % Adjusted to Book Value Calculation

Humana's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.61% / 1.74
=3.80%

Humana's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=26.35% / 1.11
=23.74%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 23.74% mean?
Humana (FRA:HUM) has a ROE % Adjusted to Book Value of 23.74% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Humana and its competitors.
Is Humana's ROE % Adjusted to Book Value too high?
Humana's current ROE % Adjusted to Book Value is 23.74%. Overall, Humana has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Humana's ROE % Adjusted to Book Value compare to CNC and CI?
Humana's ROE % Adjusted to Book Value of 23.74% can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Plans company?
A good ROE % Adjusted to Book Value depends on the Healthcare Plans industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Humana and its competitors. Humana's current ROE % Adjusted to Book Value is 23.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana stock overvalued right now?
Based on GuruFocus' analysis, Humana (FRA:HUM) is currently considered Fairly Valued. The stock's GF Value™ is €318.92, compared to a current price of €344.00 — trading 7.9% above its estimated fair value. The current ROE % Adjusted to Book Value is 23.74%. Humana's overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Humana (FRA:HUM), the current ROE % Adjusted to Book Value is 23.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Humana (FRA:HUM) Overvalued in 2026?

Based on GuruFocus' analysis, Humana stock appears to be overvalued. The current stock price of €344.00 is trading 7.9% above its estimated GF Value™ of €318.92. GuruFocus considers Humana to be Fairly Valued.

Key valuation signals for FRA:HUM:

  • ROE % Adjusted to Book Value: 23.74%
  • GF Value™: €318.92 vs. price of €344.00 (7.9% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the FRA:HUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Humana Business Description

Address 101 East Main Street, Louisville, KY, USA, 40202
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
87GF Score

Get the complete analysis for FRA:HUM

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€344.00
Price
€318.92
GF Value